CSIMarket Company Name, Ticker, Customers, else..


West Pharmaceutical Services Inc   (NYSE: WST)
Other Ticker:  
 

West Pharmaceutical Services Inc

WST's Fundamental analysis



West Pharmaceutical Services Inc 's sales fell by -0.08 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 278

Medical Equipment & Supplies industry recorded growth of revenues by 1.68 %

West Pharmaceutical Services Inc 's net profit decreased by -15.69 % in III. Quarter 2024 year on year, to $136 millions.

• More on WST's Growth


West Pharmaceutical Services Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

West Pharmaceutical Services Inc realized cash reduction of $ -5.55 per share in trailing twelve-month period.
Company
49.12
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 8.47.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.29.


• More on WST's Valuation
 
 Total Debt (Millions $) 203
 Dividend TTM ($) 0.79 $
 Dividend Yield TTM (%) 0.24 %
 Revenue/Employee (TTM) $ 271,264
 Net Income/Employee (TTM) $ 47,132
 Receivable Turnover (TTM) 5.64
 Tangible Book Value (Per Share $) 35.84

West Pharmaceutical Services Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

West Pharmaceutical Services Inc realized cash outflow of $ -5.55per share in trailing twelve-month period.
Company
49.12
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 8.47.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.29.

West Pharmaceutical Services Inc Price to Book Ratio is at 8.84 higher than Industry Avg. of -564.72, and higher than S&P 500 Avg. of 0.01

• More on WST's Valuation

•  Market Capitalization (Millions $) 24,341
•  Shares Outstanding (Millions) 73
•  Employees 10,600
•  Revenues (TTM) (Millions $) 2,875
•  Net Income (TTM) (Millions $) 500
•  Cash Flow (TTM) (Millions $) -408
•  Capital Exp. (TTM) (Millions $) -381
•  Total Debt (Millions $) 203
•  Dividend TTM ($) 0.79 $
•  Dividend Yield TTM (%) 0.24 %
•  Revenue/Employee (TTM) $ 271,264
•  Net Income/Employee(TTM) $ 47,132
•  Receivable Turnover Ratio (TTM) 5.64
•  Tangible Book Value (Per Share $) 35.84

•  Market Capitalization (Millions $) 24,341
•  Shares Outstanding (Millions) 73
•  Employees 10,600
•  Revenues (TTM) (Millions $) 2,875
•  Net Income (TTM) (Millions $) 500
•  Cash Flow (TTM) (Millions $) -408
•  Capital Exp. (TTM) (Millions $) -381


    WST's Profitability Comparisons
West Pharmaceutical Services Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 21.6 % from 17.98 % in II. Quarter.

West Pharmaceutical Services Inc net profit margin of 18.21 % is currently ranking no. 11 in Medical Equipment & Supplies industry, ranking no. 57 in Healthcare sector and number 756 in S&P 500.


Profitability by Segment
Total 18.21 %



  Ratio
•   Capital Ratio (MRQ) 3
•  Total Debt to Equity (MRQ) 0.07
•  Tangible Leverage Ratio (MRQ) 0.32
•  Asset Turnover Ratio (TTM) 0.82
•  Inventory Turnover Ratio (TTM) 4.44



West Pharmaceutical Services Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 21.6 % from 17.98 % in II. Quarter.

West Pharmaceutical Services Inc net profit margin of 18.21 % is currently ranking no. 11 in Medical Equipment & Supplies industry, ranking no. 57 in Healthcare sector and number 756 in S&P 500.

• More on WST's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com